These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25611258)

  • 21. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
    Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J
    Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma].
    Gao J; Chen M; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):432-5. PubMed ID: 15975277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dendritic cell-based immunotherapy for hepatocellular carcinoma].
    Nakamoto Y; Kaneko S
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):413-6. PubMed ID: 20332677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells.
    Du X; Bai Z; Zhang J; Liu L; Han Y; Wang Z; Huan T; Wu B
    Pathobiology; 2010; 77(3):115-28. PubMed ID: 20516727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status and perspectives of immune-based therapies for hepatocellular carcinoma.
    Aerts M; Benteyn D; Van Vlierberghe H; Thielemans K; Reynaert H
    World J Gastroenterol; 2016 Jan; 22(1):253-61. PubMed ID: 26755874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis.
    Chen S; Akbar SM; Tanimoto K; Ninomiya T; Iuchi H; Michitaka K; Horiike N; Onji M
    Cancer Lett; 2000 Jan; 148(1):49-57. PubMed ID: 10680592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the immune system in the control of hepatocellular carcinoma.
    O'Beirne JP; Harrison PM
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1257-60. PubMed ID: 15618828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.
    Wirth TC
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):101-10. PubMed ID: 24410473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma cells deteriorate the biophysical properties of dendritic cells.
    Zeng Z; Yao W; Xu X; Xu G; Long J; Wang X; Wen Z; Chien S
    Cell Biochem Biophys; 2009; 55(1):33-43. PubMed ID: 19582594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
    DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of immunotherapy for hepatocellular carcinoma.
    Breous E; Thimme R
    J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice.
    Zhang H; Zheng SS; Jiang GP; Wu LH; Zhu F; Yang ZL
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):235-40. PubMed ID: 15138117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of tumor antigen specific CTL induced by dendritic cells on a model of human hepatocellular carcinoma in nude mice (LCI-D20)].
    Chen GL; Hu HD; Ma YJ; Li YG; Xue Q; Chen M; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):431-4. PubMed ID: 16792867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives.
    Roth GS; Decaens T
    Eur J Cancer; 2017 Dec; 87():101-112. PubMed ID: 29145036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
    Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perspectives on immunotherapy for hepatocellular carcinoma].
    Schmidt N; Büttner N; Thimme R
    Dtsch Med Wochenschr; 2013 Apr; 138(14):740-4. PubMed ID: 23533044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunotherapy for hepatocellular carcinoma using dendritic cells].
    Homma S; Toda G; Ohno T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():693-8. PubMed ID: 11762039
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.
    Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y
    Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide.
    Long J; Zhou B; Li H; Dai Q; Zhang B; Xing S; Zeng Z; Chen W; Yang J
    Immunol Invest; 2013; 42(2):137-55. PubMed ID: 23323523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.